Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Joyce

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Health Affairs Scholar|July 25, 2025
The cost of misaligned incentives in the pharmaceutical supply chainGeoffrey Joyce
The Journal of Urology|March 11, 2005
Economic costs of benign prostatic hyperplasia in the private sectorChristopher S Saigal, Geoffrey Joyce
The American Journal of Managed Care|April 27, 2023
Part D beneficiaries' incentives and responses under preferred pharmacy networksJianhui Xu, Erin Trish, Geoffrey Joyce
Health Affairs Scholar|April 15, 2026
The changing Part D landscapeGeoffrey Joyce, Beier Chen, Barbara Blaylock
Medical Care Research and Review : MCRR|August 23, 2019
Incorporating Prescription Drug Utilization Information Into the Marketplace Risk Adjustment Model Improves Payment Accuracy and Reduces Adverse Selection IncentivesJianhui Xu, Erin Trish, Geoffrey Joyce
Health Services Research|March 17, 2022
Pharmacy switching in response to preferred pharmacy networks in Medicare Part DJianhui Xu, Erin Trish, Geoffrey Joyce
Health Affairs (Project Hope)|July 10, 2018
Growing Number Of Unsubsidized Part D Beneficiaries With Catastrophic Spending Suggests Need For An Out-Of-Pocket CapErin Trish, Jianhui Xu, Geoffrey Joyce
The American Journal of Managed Care|November 16, 2020
Variation in generic dispensing rates in Medicare Part DChristine Buttorff, Yifan Xu, Geoffrey Joyce
Health Affairs (Project Hope)|September 9, 2016
Medicare Beneficiaries Face Growing Out-Of-Pocket Burden For Specialty Drugs While In Catastrophic Coverage PhaseErin Trish, Jianhui Xu, Geoffrey Joyce
Health Economics|November 20, 2023
Why higher copayments for opioids did not reduce use among Medicare beneficiariesGeoffrey Joyce, Bo Zhou, Robert Kaestner
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Health Affairs Scholar|July 25, 2025
The cost of misaligned incentives in the pharmaceutical supply chainGeoffrey Joyce
The Journal of Urology|March 11, 2005
Economic costs of benign prostatic hyperplasia in the private sectorChristopher S Saigal, Geoffrey Joyce
The American Journal of Managed Care|April 27, 2023
Part D beneficiaries' incentives and responses under preferred pharmacy networksJianhui Xu, Erin Trish, Geoffrey Joyce
Health Affairs Scholar|April 15, 2026
The changing Part D landscapeGeoffrey Joyce, Beier Chen, Barbara Blaylock
Medical Care Research and Review : MCRR|August 23, 2019
Incorporating Prescription Drug Utilization Information Into the Marketplace Risk Adjustment Model Improves Payment Accuracy and Reduces Adverse Selection IncentivesJianhui Xu, Erin Trish, Geoffrey Joyce
Health Services Research|March 17, 2022
Pharmacy switching in response to preferred pharmacy networks in Medicare Part DJianhui Xu, Erin Trish, Geoffrey Joyce
Health Affairs (Project Hope)|July 10, 2018
Growing Number Of Unsubsidized Part D Beneficiaries With Catastrophic Spending Suggests Need For An Out-Of-Pocket CapErin Trish, Jianhui Xu, Geoffrey Joyce
The American Journal of Managed Care|November 16, 2020
Variation in generic dispensing rates in Medicare Part DChristine Buttorff, Yifan Xu, Geoffrey Joyce
Health Affairs (Project Hope)|September 9, 2016
Medicare Beneficiaries Face Growing Out-Of-Pocket Burden For Specialty Drugs While In Catastrophic Coverage PhaseErin Trish, Jianhui Xu, Geoffrey Joyce
Health Economics|November 20, 2023
Why higher copayments for opioids did not reduce use among Medicare beneficiariesGeoffrey Joyce, Bo Zhou, Robert Kaestner
Pageof 5